UPDATE 1-Biogen, AbbVie once-monthly MS injection wins U.S. approval
May 27, 2016 at 18:43 PM EDT
May 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc, with a boxed warning.